ScoreWhy is Apyx Medical Corp. ?
1
Poor long term growth as Operating profit has grown by an annual rate 10.92% of over the last 5 years
2
With a growth in Net Sales of 32.45%, the company declared Very Positive results in Mar 26
- The company has declared positive results for the last 5 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD -7.87 MM
- NET PROFIT(HY) Higher at USD -3.41 MM
- ROCE(HY) Highest at -78.56%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 140.35%, its profits have risen by 52.8%
4
High Institutional Holdings at 48.7%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
5
Market Beating Performance
- The stock has generated a return of 140.35% in the last 1 year, much higher than market (S&P 500) returns of 25.41%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Apyx Medical Corp. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Apyx Medical Corp. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Apyx Medical Corp.
140.35%
1.78
88.27%
S&P 500
25.41%
1.92
13.25%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
13.78%
EBIT Growth (5y)
10.92%
EBIT to Interest (avg)
-12.91
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.33
Sales to Capital Employed (avg)
1.04
Tax Ratio
1.25%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
48.70%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
10.47
EV to EBIT
-24.17
EV to EBITDA
-26.90
EV to Capital Employed
8.62
EV to Sales
2.95
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-35.66%
ROE (Latest)
-76.38%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend18What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -7.87 MM
NET PROFIT(HY)
Higher at USD -3.41 MM
ROCE(HY)
Highest at -78.56%
RAW MATERIAL COST(Y)
Fallen by -37.92% (YoY
INVENTORY TURNOVER RATIO(HY)
Highest at 4.04 times
DEBTORS TURNOVER RATIO(HY)
Highest at 4.58 times
NET SALES(Q)
At USD 12.49 MM has Grown at 32.45%
PRE-TAX PROFIT(Q)
At USD -2 MM has Grown at 51.49%
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Apyx Medical Corp.
Net Profit
Higher at USD -3.41 MM
than preceding 12 month period ended Mar 2026MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Net Profit
At USD -3.41 MM has Grown at 61.19%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Operating Cash Flow
Highest at USD -7.87 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
At USD 12.49 MM has Grown at 32.45%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Pre-Tax Profit
At USD -2 MM has Grown at 51.49%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Inventory Turnover Ratio
Highest at 4.04 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 4.58 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -37.92% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
